Clinical Trial

Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome

Study acronym: ODT-CRS
Recruiting
View on ClinicalTrials.gov →
Summary
To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-05-26.
Trial Details
NCT Number NCT05397392
Lead Sponsor Nanjing First Hospital, Nanjing Medical University
Conditions Heart Failure, Kidney Diseases, Kidney Injury, Heart Valve Diseases, Dialysis; Complications, Coronary Heart Disease
Enrollment 1,200 participants
Start Date 2016-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2022-06-02